Logo image
Sequential Drug Delivery to Modulate Macrophage Behavior and Enhance Implant Integration
Journal article   Open access   Peer reviewed

Sequential Drug Delivery to Modulate Macrophage Behavior and Enhance Implant Integration

Erin M. O’Brien, Gregory E. Risser and Kara L. Spiller
Advanced drug delivery reviews, v 149-150
01 Jan 2019
PMID: 31103451
url
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6858522View
Accepted (AM)Open Access (License Unspecified) Open

Abstract

angiogenesis implant integration macrophage
Macrophages are major upstream regulators of the inflammatory response to implanted biomaterials. Sequential functions of distinct macrophage phenotypes are essential to the normal tissue repair process, which ideally results in vascularization and integration of implants. Improper timing of M1 or M2 macrophage activation results in dysfunctional healing in the form of chronic inflammation or fibrous encapsulation of the implant. Thus, biphasic drug delivery systems that modulate macrophage behavior are an appealing approach to promoting implant integration. In this review, we describe the timing and roles of macrophage phenotypes in healing, then highlight current drug delivery systems designed to sequentially modulate macrophage behavior.

Metrics

10 Record Views
106 citations in Scopus

Details

UN Sustainable Development Goals (SDGs)

This publication has contributed to the advancement of the following goals:

#3 Good Health and Well-Being

InCites Highlights

Data related to this publication, from InCites Benchmarking & Analytics tool:

Web of Science research areas
Pharmacology & Pharmacy
Logo image